Trial Information
Oocyte Cryopreservation in Assisted Reproduction
Inclusion Criteria:
1. 10 women between the ages of 18-35 inclusive at time of signing Informed Consent
Form.
2. In good general health off of current medications which may confound response to
study medications.
3. Desire to seek pregnancy actively during the study period by IVF-ICSI.
4. A normal uterine cavity must have been confirmed by either hydrosonogram or
hysteroscopy within two years of entering the study.
5. Ability to use the required medications.
6. Day 3 FSH level < 12 IU/ml
Exclusion Criteria:
1. Current pregnancy
2. Patients with significant anemia (Hemoglobin < 10 mg/dL).
3. Patients enrolled simultaneously into other investigative studies that would
interfere with this research study.
Type of Study:
Interventional
Study Design:
Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Outcome Measure:
Incidence of Biochemical Pregnancy
Principal Investigator
Peter G. McGovern, MD
Investigator Role:
Principal Investigator
Investigator Affiliation:
UMDNJ-NJMS
Authority:
United States: Institutional Review Board
Study ID:
IRB 0120080226
NCT ID:
NCT00839839
Start Date:
February 2009
Completion Date:
February 2011
Related Keywords:
- Infertility
- Egg Freezing
- infertility
- egg freezing
- fertility preservation
- Infertility
Name | Location |
University Reproductive Associates |
Hasbrouck Heights, New Jersey 07604 |